.Sanofi has actually made an overdue entry to the radioligand celebration, spending one hundred thou...
.After F2G's initial attempt to get a brand-new training class of antifungal to market was derailed ...
.Moderna has promised to cut R&D costs through $1.1 billion through 2027. The selection to retrac...
.Just four months after Sanofi wager $80 thousand in upfront cash money on Key Therapeutics' losmapi...
.Cancer cells provider Oncternal Therapeutics is actually folding all its own professional tests and...
.Roche is actually holding out chances that its injectable excessive weight prospect can inevitably ...
.Novo Nordisk has actually lifted the cover on a period 1 test of its dental amylin and also GLP-1 r...
.Just a few brief full weeks after gaining an FDA Fast lane tag for its investigational BTK degrader...
.Shortly after a beneficial information reduce for Eli Lilly's efsitora alfa, the Indianapolis-based...
.BridgeBio Pharma is actually slashing its own genetics therapy budget and pulling back from the mod...